News

Irish Pharmaceutical Healthcare Association launches EU  manifesto in each of the Ireland constituencies ahead of upcoming European Parliament Elections.

New data compiled by industry shows lengthy timelines for access to new medicines that improve care standards in Ireland Two years in the reimbursement process is too […]

Delayed access to time-critical new medicines, the focus of an Oireachtas briefing session. Interrupting the continuous flow of new medicines due to lack of investment is […]

Contrary to popular belief, a general internet search and social media are some of the least likely sources that people would consider when it comes to […]

Scientific innovation has advanced significantly over the past number of years bringing new hope and therapies to patients around the globe. Unfortunately, as a result of […]

Amgen, MSD and Gilead feature in IPHA’s campaign that demonstrates the promise of science through animation style storytelling. Thursday, 14th September 2023 The Irish Pharmaceutical Healthcare […]

Last Friday, June 30th, IPHA published the Transfer of value (ToV) Disclosure data for 2022. The total ToV amount for 2022 was €26,140,927 which is a […]

In 2022, it took on average 567 days from EMA authorisation to availability to patients of new innovative medicines in Ireland, among the slowest in western […]

Annual Conference to assess innovation pipeline and supportive policies Proposals from the European Commission to weaken intellectual property rights will degrade the development and delivery of […]